Equities researchers at StockNews.com initiated coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Get Free Report) in a research note issued to investors on Thursday. The firm set a “hold” rating on the stock.
Brooklyn ImmunoTherapeutics Trading Up 0.6 %
Shares of NYSE BTX opened at $1.81 on Thursday. The company has a 50 day simple moving average of $1.90 and a two-hundred day simple moving average of $1.97. The stock has a market cap of $106.48 million, a price-to-earnings ratio of -0.80 and a beta of 4.61. Brooklyn ImmunoTherapeutics has a 12 month low of $0.17 and a 12 month high of $10.10.
About Brooklyn ImmunoTherapeutics
Read More
- Five stocks we like better than Brooklyn ImmunoTherapeutics
- Why is the Ex-Dividend Date Significant to Investors?
- 3M Surprises and Rebound Accelerates: It Isn’t Too Late To Get In
- NYSE Stocks Give Investors a Variety of Quality OptionsÂ
- Skechers Stock Shows Strength Among Consumer Discretionary Sector
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Tech Stocks Tumble, These Stocks Present Buying Opportunity
Receive News & Ratings for Brooklyn ImmunoTherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brooklyn ImmunoTherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.